BioNTech-Pfizer Vaccine Shows Mixed Trial Results
PremiumCompany AnnouncementsBioNTech-Pfizer Vaccine Shows Mixed Trial Results
8d ago
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
Premium
Press Releases
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age
8d ago
Pfizer, BioNTech provide update on mRNA-based combination vaccine program
Premium
The Fly
Pfizer, BioNTech provide update on mRNA-based combination vaccine program
8d ago
BioNTech price target lowered to $97 from $101 at UBS
PremiumThe FlyBioNTech price target lowered to $97 from $101 at UBS
18d ago
BioNTech price target lowered to $85 from $98 at TD Cowen
Premium
The Fly
BioNTech price target lowered to $85 from $98 at TD Cowen
18d ago
Options Volatility and Implied Earnings Moves Today, August 05, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 05, 2024
19d ago
Genmab to assume full control of development, commercialization of acasunlimab
PremiumThe FlyGenmab to assume full control of development, commercialization of acasunlimab
19d ago
BNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
BNTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
22d ago
BioNTech’s BNT111 Shows Promise in Melanoma Treatment
Premium
Company Announcements
BioNTech’s BNT111 Shows Promise in Melanoma Treatment
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100